At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
The Associate Director of Value Generation plays a critical role in developing resources that are crucial to communicating the value story of our products to organized customers and payers. This position will be part of a team of high-performing individuals focused on the development and communication of strategies and tools to support access for the entire franchise. They will collaborate with US Field and HQ Health Economics and Outcomes Research (HEOR) teams to reinvent engagement and execute on building innovative and/or custom solutions to meet the needs of BMS Access Customers.
Responsibilities include:
* Inform strategy for and development of customer facing marketing materials that are tailored to fit various Channels, Segments, or Stakeholders
* Lead the development and execution of FDAMA 114 marketing materials for their assigned therapeutic area (Cardiovascular and Immuno-science or Hematology) to proactively communicate HCEI to payers and other formulary decision-makers
* Lead the effort to develop a suite of integrated products and services for US Field HEOR team pertaining to but not limited to tools such as Value Proposition resources, reactive decks, long-term Epidemiology models, and outcomes analyzers to differentiate BMS in the US Payer/Organized Customer landscape for their assigned therapeutic area (Cardiovascular and Immuno-science or Hematology)
* Lead the development of the reactive resources for the US Field HEOR team for their assigned therapeutic area (Cardiovascular and Immuno-science or Hematology)
* Ensure strong partnership with cross-functional matrix, including payer marketing and HQ HEOR to ensure HCEI alignment with brand/access strategies for both near-term execution, and longer-term HCEI planning and data generation.
* Collaborate with cross-functional team members for strategy development and tactical execution, including: HQ HEOR, Payer Marketing, Professional Marketing, Medical, Pricing, Field Access, Learning & Development, and PReP advisors (e.g., Legal, Medical, Regulatory review).
* Shepherd tools and materials through the legal and regulatory approval process
Candidate Specifications:
* BA/BS degree or equivalent, MS or PhD, Pharm D, preferred
* Track record of highly ethical and compliant behavior
* 3 to 5 years (Associate Director) or 1 to 3 years (Senior Manager) of relevant experience, which may include market access, regulatory review, HEOR, and consulting experience
* Exceptional interpersonal and communication skills to effectively and efficiently drive performance within a matrix organization, and form strong, productive partnerships
* Ability to work across boundaries and partner with various stakeholders to build consensus and get results
* Demonstrated ability to work effectively with strong problem solving and communications skills.
* Previous experience overseeing projects with the ability to work autonomously with minimal supervision.
* Experience working with cross-functional teams to accomplish specified goals, and make an impact
* Demonstrated ability to drive execution of key initiatives and meet all deadlines
* Strong ability to prioritize and work effectively in a fast-paced, dynamic environment
* Strong business acumen including a solid understanding of business models of various customer types
* Experience in translating insights and strategies into effective strategies and marketing resources
* Strong analytical skills and ability to think and strategically plan within a complex ecosystem/market
Preferred Qualifications:
* MBA degree or advanced technical degree or clinical degree preferred (e.g., PharmD, PhD, MD, MSc)
* Experience managing direct reports
* Experience working within their assigned therapeutic area (Cardiovascular and Immuno-science or Hematology)
* Experience and knowledge of promotional regulatory processes
* Understanding of healthcare economics, epidemiology, quality of life and clinical research.
* Strong understanding of US Marketing, Managed Care and formulary issues.
* Understanding of statistical methods and tests.
* Understanding of healthcare economics, epidemiology, quality of life and health sciences research.
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
New York, New York
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.
It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.
The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.